IFNB1 and neoplasm: Biological cues such as lipopolysaccharides, interferon‐beta (IFN‐β), and transforming growth factor‐β (TGF‐β) inhibitors have been reported to induce NE phenotype switch from a pro‐tumor N2 to anti‐tumor N1 type.47